Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ABCB1 is an ATP-dependent efflux pump responsible for transporting a wide variety of drugs and other substances out of cells. It plays a critical role in multidrug resistance, particularly in cancer, and impacts the pharmacokinetics of many clinically used drugs. It is highly expressed at blood-organ barriers where it protects tissues from toxic substances. Genetic variants influence individual drug responses, which can lead to drug toxicity or therapeutic failure. The protein consists of two pseudosymmetric halves, each containing a transmembrane domain (TMD) and a nucleotide-binding domain (NBD). The TMDs form a central drug-binding pocket surrounded by 12 transmembrane helices. It belongs to one of seven distinct subfamilies within the large superfamily of human ATP-binding cassette (ABC) transporters.
ATP hydrolysis-driven active transport via alternating access mechanism
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on ATP-binding cassette subfamily B member 1 (ABCB1).